Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers
Clinical trial NCT06254235 · COMPLETED
Trial details
- NCT number
- NCT06254235
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-16
- Primary completion
- 2021-12-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.